Switching TNF-alpha antagonists in rheumatoid arthritis: The experience of the LORHEN registry-Reference-Cited by-同舟云学术

Switching TNF-alpha antagonists in rheumatoid arthritis: The experience of the LORHEN registry

Published:2010-04 Issue:6 Volume:9 Page:465-469
ISSN:1568-9972
Container-title:Autoimmunity Reviews
language:en
Short-container-title:Autoimmunity Reviews

Author:

Caporali Roberto,Sarzi-Puttini Piercarlo,Atzeni Fabiola,Gorla Roberto,Filippini Matteo,Marchesoni Antonio,Favalli Ennio Giulio,Bobbio-Pallavicini Francesca,Montecucco Carlomaurizio

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference40 articles.

1. Treatment of rheumatoid arthritis with anti-TNF-alpha agents: a reappraisal;Caporali;Autoimmun Rev,2009

2. New therapies for treatment of rheumatoid arthritis;Smolen;Lancet,2007

3. TNF-alpha antagonist survival rate in a cohort of rheumatoid arthritis patients observed under conditions of standard clinical practice;Marchesoni;Ann N Y Acad Sci,2009

4. Anti-TNFalpha therapy in a cohort of rheumatoid arthritis patients: clinical outcomes;Bazzani;Autoimmun Rev,2009

5. Switching between anti-tumour necrosis factors: trying to get a handle on a complex issue;van Vollenhoven;Ann Rheum Dis,2007

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Safety Profile of Biologics Used in Rheumatology: A Six-Year Observational Pharmacovigilance Study in the Calabria Region;Pharmaceutics;2022-10-28

2. Large-Scale Postmarketing Surveillance of Biological Drugs for Immune-Mediated Inflammatory Diseases Through an Italian Distributed Multi-Database Healthcare Network: The VALORE Project;BioDrugs;2021-10-12

3. Working and safety profiles of JAK/STAT signaling inhibitors. Are these small molecules also smart?;Autoimmunity Reviews;2021-03

4. Cost-utility analysis of treatment options after initial tumor necrosis factor inhibitor therapy discontinuation in patients with rheumatoid arthritis;Journal of Managed Care & Specialty Pharmacy;2021-01

5. Safety Profile of Biologics Used in Rheumatology: An Italian Prospective Pharmacovigilance Study;Journal of Clinical Medicine;2020-04-24